Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages 502-507

  Hansen, John Bjarne ^a,b   Fernández, José A ^b   Borch, Knut H ^a   Griffin, John H ^b   Brox, Jan H ^a   Braekkan, Sigrid K ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Activated protein C; Coagulation activation; Postprandial lipemia; Venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOLYTIC AGENT; HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 LEIDEN DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FAT TOLERANCE TEST; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LUNG EMBOLISM; MALE; POPULATION BASED CASE CONTROL STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN DEFICIENCY; THROMBIN TIME; VASCULAR SURGERY; VENOUS THROMBOEMBOLISM; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PROTEIN C; VENOUS THROMBOEMBOLISM;

EID: 84858334558     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.06.026     Document Type: Article

References (34)

1. C.T. Esmon, W. Ding, K. Yasuhiro, J.M. Gu, G. Ferrell, and L.M. Regan The protein C pathway: New insights Thromb Haemost 78 1997 70 74
2. J.H. Griffin, B. Evatt, C. Wideman, and J.A. Fernandez Anticoagulant protein C pathway defective in majority of thrombophilic patients Blood 82 1993 1989 1993
3. K.A. Bauer, B.L. Kass, D.L. Beeler, and R.D. Rosenberg Detection of protein C activation in humans J Clin Invest 74 1984 2033 2041
4. M.J. Heeb, D. Mosher, and J.H. Griffin Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation Blood 73 1989 455 461
5. A. Gruber, and J.H. Griffin Direct detection of activated protein C in blood from human subjects Blood 79 1992 2340 2348
6. F. Espana, I. Zuazu, V. Vicente, A. Estelles, P. Marco, and J. Aznar Quantification of circulating activated protein C in human plasma by immunoassays-enzyme levels are proportional to total protein C levels Thromb Haemost 75 1996 56 61
7. C.T. Esmon Molecular events that control the protein C anticoagulant pathway Thromb Haemost 70 1993 29 35
8. C.T. Esmon The endothelial cell protein C receptor Thromb Haemost 83 2000 639 643
9. F.J. Walker Regulation of activated protein C by a new protein. A possible function for bovine protein S J Biol Chem 255 1980 5521 5524
10. J.H. Griffin, K. Kojima, C.L. Banka, L.K. Curtiss, and J.A. Fernandez High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C J Clin Invest 103 1999 219 227
11. S. Yegneswaran, H. Deguchi, and J.H. Griffin Glucosylceramide, a neutral glycosphingolipid anticoagulant cofactor, enhances the interaction of human- and bovine-activated protein C with negatively charged phospholipid vesicles J Biol Chem 278 2003 14614 14621
12. J.A. Fernandez, K. Kojima, J. Petaja, T.M. Hackeng, and J.H. Griffin Cardiolipin enhances protein C pathway anticoagulant activity Blood Cells Mol Dis 26 2000 115 123
13. M.D. Smirnov, and C.T. Esmon Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C J Biol Chem 269 1994 816 819
14. F. Espana, A. Vaya, Y. Mira, P. Medina, A. Estelles, and P. Villa Low level of circulating activated protein C is a risk factor for venous thromboembolism Thromb Haemost 86 2001 1368 1373
15. M. Cattaneo, F. Franchi, M.L. Zighetti, I. Martinelli, D. Asti, and P.M. Mannucci Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels Arterioscler Thromb Vasc Biol 18 1998 1371 1375
16. G.J. Miller, J.C. Martin, K.A. Mitropoulos, B.E. Reeves, R.L. Thompson, and T.W. Meade Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition Atherosclerosis 86 1991 163 171
17. A. Nordoy, B. Svensson, and J.B. Hansen Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia J Thromb Haemost 1 2003 690 697
18. A. Nordoy, K.H. Bonaa, P.M. Sandset, J.B. Hansen, and H. Nilsen Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia Arterioscler Thromb Vasc Biol 20 2000 259 265
19. S.K. Braekkan, E.B. Mathiesen, I. Njolstad, T. Wilsgaard, J. Stormer, and J.B. Hansen Family history of myocardial infarction is an independent risk factor for venous thromboembolism: The Tromso study J Thromb Haemost 6 2008 1851 1857
20. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, and H. de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
21. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
22. R.H. White The epidemiology of venous thromboembolism Circulation 107 2003 I4 I8
23. E.M. Faioni, F. Franchi, D. Asti, and P.M. Mannucci Activation of the protein C pathway in hereditary thrombophilia Thromb Haemost 80 1998 557 560
24. K. Strandberg, P. Bhiladvala, J. Holm, and J. Stenflo A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes Blood Coagul Fibrinolysis 12 2001 503 510
25. K. Minamikawa, H. Wada, Y. Wakita, M. Ohiwa, M. Tanigawa, and K. Deguchi Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism Thromb Haemost 71 1994 192 194
26. F. Espana, V. Vicente, D. Tabernero, I. Scharrer, and J.H. Griffin Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease Thromb Res 59 1990 593 608
27. K. Strandberg, J. Astermark, O. Bjorgell, C. Becker, P.E. Nilsson, and J. Stenflo Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis Thromb Haemost 86 2001 1400 1408
28. K. Strandberg, J. Stenflo, C. Nilsson, and P.J. Svensson APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden J Thromb Haemost 3 2005 2578 2580
29. K. Strandberg, M. Kjellberg, R. Knebel, H. Lilja, and J. Stenflo A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor Thromb Haemost 86 2001 604 610
30. J. Lopez-Miranda, C. Williams, and D. Lairon Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism Br J Nutr 98 2007 458 473
31. A. Silveira, F. Karpe, M. Blomback, G. Steiner, G. Walldius, and A. Hamsten Activation of coagulation factor VII during alimentary lipemia Arterioscler Thromb 14 1994 60 69
32. P. Raivio, J.A. Fernandez, A. Kuitunen, J.H. Griffin, R. Lassila, and J. Petaja Activation of protein C and hemodynamic recovery after coronary artery bypass surgery J Thorac Cardiovasc Surg 133 2007 44 51
33. M. Ilmakunnas, E.J. Pesonen, K. Hockerstedt, H. Makisalo, J.A. Fernandez, and J.H. Griffin Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation Crit Care Med 34 2006 426 432
34. R.M. Mesters, J. Helterbrand, B.G. Utterback, B. Yan, Y.B. Chao, and J.A. Fernandez Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications Crit Care Med 28 2000 2209 2216